FDA approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults with treatment-resistant depression
Read more: FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic